|Bid||0.3800 x 0|
|Ask||0.3850 x 0|
|Day's Range||0.3750 - 0.3950|
|52 Week Range||0.2800 - 0.8900|
|Beta (5Y Monthly)||-0.50|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb. 14, 2020 - Feb. 17, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.13|
Toronto, Ontario--(Newsfile Corp. - June 30, 2020) - Antibe Therapeutics Inc. (TSXV: ATE) ("Antibe" or the "Company") announced that it closed its previously announced bought deal public offering of 62,500,000 units of the Company (the "Units") at a price of $0.40 per Unit (the "Offering Price") plus the exercise in full of the Underwriters' over-allotment option of 9,375,000 units for aggregate gross proceeds of $28,750,000 (the "Offering"). The Offering was made pursuant to an ...
VANCOUVER, BC , June 10, 2020 /CNW/ - Trading resumes in: Company: Antibe Therapeutics Inc. TSX-Venture Symbol: ATE (all issues) Resumption (ET): 9:30 AM IIROC can make a decision to impose a temporary ...
VANCOUVER, BC , June 9, 2020 /CNW/ - The following issues have been halted by IIROC: Company: Antibe Therapeutics Inc. TSX-Venture Symbol: ATE (all issues) Reason: At the Request of the Company Pending ...
ANTIBE THERAPEUTICS TO HOST CONFERENCE CALL TO DISCUSS POSITIVE RESULTS OF PHASE 2B DOSE-RANGING, EFFICACY STUDY FOR ATB-346
ANTIBE THERAPEUTICS ANNOUNCES POSITIVE TOP-LINE DATA FROM PHASE 2B DOSE-RANGING, EFFICACY STUDY FOR ATB-346
ANTIBE THERAPEUTICS UPDATES TIMING FOR TOP-LINE RESULTS FROM COMPLETED PHASE 2B DOSE-RANGING, EFFICACY STUDY
The LOI outlines the principal terms and conditions which will result in a reverse takeover of Klinik by NeuPath (the "Transaction"). Klinik is a Capital Pool Company and intends for the Transaction to constitute its Qualifying Transaction, as such terms are defined in the policies of the TSX Venture Exchange (the "TSXV").
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...